Insider Transactions in Q4 2024 at Xeris Biopharma Holdings, Inc. (XERS)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 22
2024
|
Steven Pieper Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,483
+1.33%
|
$19,483
$1.55 P/Share
|